inovmedИнновационная медицина КубаниInnovative Medicine of Kuban2541-9897Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 110.35401/2500-0268-2022-25-1-77-82inovmed-510Research ArticleОБЗОРЫREVIEWSИнтраоперационная лучевая терапия в лечении раннего рака молочной железы. От прошлого к будущемуIntraoperative radiation therapy in the treatment of breast cancer. From the past to the futurehttps://orcid.org/0000-0002-7834-7042ЧумаченкоИ. С.ChumachenkoI. S.

Чумаченко Игорь Сергеевич, врач-онколог онкологического отделения № 8

350040, Краснодар, ул. Димитрова, 146

Igor S. Chumachenko, Oncologist of the Oncology Department no. 8

146, Dimitrova str., Krasnodar, 350040

appchumachenko@mail.ruhttps://orcid.org/0000-0001-8873-8461МурашкоР. А.MurashkoR. A.

Мурашко Роман Алексеевич, к. м. н., главный врач

Краснодар

Roman A. Murashko, Cand. Sci. (Med.), Chief Physician

Krasnodar

https://orcid.org/0000-0002-5135-4111КешабянА. А.KeshabyanA. A.

Кешабян Артур Арамович, к. м. н., заведующий онкологическим отделением № 8

Краснодар 

Arthur A. Keshabyan, Cand. Sci. (Med.), Head of the Oncology Department no. 8

Krasnodar

Клинический онкологический диспансер № 1РоссияClinical Oncology Dispensary no. 1Russian Federation202230032022017782Copyright © Чумаченко И.С., Мурашко Р.А., Кешабян А.А., 20222022Чумаченко И.С., Мурашко Р.А., Кешабян А.А.Chumachenko I.S., Murashko R.A., Keshabyan A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.innovmedkub.ru/jour/article/view/510

В статье рассматривается опыт применения интраоперационной лучевой терапии в лечении больных раком молочной железы на ранней стадии, а также пути развития данного направления с точки зрения перспектив (улучшения качества лечения, снижения выраженности побочных эффектов, отсутствия влияния на соседние органы) и рисков (вероятности локального рецидивирования) для пациентов.

This article discusses the experience of using intraoperative radiation therapy in the treatment of patients with breast cancer, as well as the prospects for the development of this area in terms of benefits (improved therapy effect, reduced severity of side effects, no effect on adjacent organs) and risks (the possibility of local recurrence) for patients.

рак молочной железыинтраоперационная лучевая терапиялучевая терапияпарциальное облучениеbreast cancerintraoperative radiation therapyradiation therapypartial irradiationReferencesForman D, Bray F, Brewster DH, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–2071. PMID: 26135522. http://doi.org/10.1002/ijc.29670Forman D, Bray F, Brewster DH, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 2015;137(9):2060–2071. PMID: 26135522. http://doi.org/10.1002/ijc.29670Мерабишвили В.М. Онкологическая служба Санкт­Петербурга (оперативная отчетность за 2011–2012 годы, углубленная разработка базы данных регистра по международным стандартам). Популяционный раковый регистр (IACR № 221), том 18. Под ред. В.М. Колабутина, А.М. Беляева. СПб: Издательско-полиграфическая компания «КОСТА»; 2013;364.Merabishvili VM. Cancer Control in St. Petersburg (operative report for 2011–2012, precise elaboration of registry’s database by international standards). Population­based Cancer Registry (IACR no. 221) Sci. publ. no. 18. Eds. Kolabutina VM, Belyaeva AM. Saint Petersburg: LLC “Publishing and printing company ‘COSTA’; 2013;364. (In Russ.).Чёрная А.В., Канаев С.В., Новиков С.Н. и др. Маммография и маммосцинтиграфия с 99м ТС-MIBI в диагностике мультицентричного рака молочной железы. Вопросы онкологии. 2017;63(2):274–280. https://doi.org/10.37469/0507-3758-2017-63-6-876-881Chernaya АV, Kanaev SV, Novikov SN, et al. Mammography and mammoscintigraphy with 99m TC-MIBI in the detection of multicentric breast cancer. Questions of Oncology. 2017;63(2):274–280. (In Russ.). https://doi.org/10.37469/0507-3758-2017-63-6-876-881Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108(2):197–202. PMID: 23742961. https://doi.org/10.1016/j.radonc.2013.05.008Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108(2):197–202. PMID: 23742961. https://doi.org/10.1016/j.radonc.2013.05.008Polgar C, Ott OJ, Hildebrandt G, et al. Late side effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast conserving surgery for low-risk invasive and in situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(2):259–268. PMID: 28094198. https://doi.org/10.1016/S1470-2045(17)30011-6Polgar C, Ott OJ, Hildebrandt G, et al. Late side effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast conserving surgery for low-risk invasive and in situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(2):259–268. PMID: 28094198. https://doi.org/10.1016/S1470-2045(17)30011-6Чумаченко И.С., Мурашко Р.А., Кешабян А.А. и др. Результаты органосохраняющего лечения рака молочной железы с применением интраоперационной лучевой терапии. Опухоли женской репродуктивной системы. 2021;17(3):16–23. https://doi.org/10.17650/1994-4098-2021-17-3-16-23Chumachenko IS, Murashko RA, Keshabyan AA, et al. Results of organ-preserving treatment of breast cancer using intraoperative radial therapy. Tumors of female reproductive system. 2021;17(3):16–23. (In Russ.). https://doi.org/10.17650/1994-4098-2021-17-3-16-23Veronesi U, Luini A, Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587–1591. PMID: 8387637. https://doi.org/10.1056/NEJM199306033282202Veronesi U, Luini A, Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587–1591. PMID: 8387637. https://doi.org/10.1056/NEJM199306033282202Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol. 1992;8(3):161–166. PMID: 1496227.Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol. 1992;8(3):161–166. PMID: 1496227.Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56(5):979–990. PMID: 2990668. https://doi.org/10.1002/1097-0142(19850901)56:5%3C979::aid-cncr2820560502%3E3.0.co;2-nHolland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56(5):979–990. PMID: 2990668. https://doi.org/10.1002/1097-0142(19850901)56:5%3C979::aid-cncr2820560502%3E3.0.co;2-nБрянцева Ж.В., Акулова И.А., Новиков С.Н. и др. Внутритканевая брахитерапия источниками высокой мощности дозы в лечении больных раком молочной железы. Онкологический журнал: лучевая диагностика, лучевая терапия. 2019;2(4):26–34. http://doi.org/10.37174/2587-7593-2019-2-4-26-34Bryantseva ZV, Akulova IA, Novikov SN, et al. High Dose Rate Brachytherapy in Treatment of Breast Cancer Patients. Journal of oncology: diagnostic radiology and radiotherapy. 2019;2(4):26–34. (In Russ.). https://doi.org/10.37174/2587-7593-2019-2-4-26-34Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25(22):3259–3265. PMID: 17577015. https://doi.org/10.1200/jco.2007.11.4991Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25(22):3259–3265. PMID: 17577015. https://doi.org/10.1200/jco.2007.11.4991Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–659. PMID: 11241230. https://doi.org/10.1002/1097-0142(20010215)91:4<647::aid-cncr1053>3.0.co;2-zFaverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–659. PMID: 11241230. https://doi.org/10.1002/1097-0142(20010215)91:4<647::aid-cncr1053>3.0.co;2-zVeronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14:1269–1277. PMID: 24225155. https://doi.org/10.1016/S1470-2045(13)70497-2Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14:1269–1277. PMID: 24225155. https://doi.org/10.1016/S1470-2045(13)70497-2Захарова Н.А., Семиглазов В.Ф., Даффи С.В. Скрининг рака молочной железы: проблемы и решения. М.: ГЭОТАР-Медиа; 2011;176.Zakharova NA, Semiglazov VF, Duffy SW. Screening of the mammary gland cancer. Мoscow: GEOTAR-Media; 2011;176. (In Russ.).Семиглазов В.Ф. Скрининг для раннего выявления рака молочной железы. Медицинский альманах. 2008;4:63–65.Semiglazov VF. Screening for early diagnostics of breast cancer. Medical almanac. 2008;4:63–65. (In Russ.).Семиглазов В.Ф., Семиглазов В.В. Скрининг рака молочной железы. Практическая онкология. 2010;11(2):60–65.Semiglazov VF, Semiglazov VV. Screening of mammary gland cancer. Practical Oncology. 2010;11(2):60–65. (In Russ.).Willich N. Technical and methodical developments of radiation oncology from a physician’s point of view. Strahlenther Onkol. 2012;188(3):253–262. PMID: 22895626. (In German). https://doi.org/10.1007/s00066-012-0190-4Willich N. Technical and methodical developments of radiation oncology from a physician’s point of view. Strahlenther Onkol. 2012;188(3):253–262. PMID: 22895626. (In German). https://doi.org/10.1007/s00066-012-0190-4Скоропад В.Ю., Бердов Б.А. История и современное состояние клинического использования интраоперационной лучевой терапии у больных раком желудка. Российский онкологический журнал. 1998;5:55–58.Skoropad VYu, Berdov BA. The history and modern state of clinical usage of the intraoperative radiation therapy in patients with stomach cancer. Russian Journal of Oncology. 1998;5:55–58. (In Russ.).Kulcenty K, Piotrowski I, Wróblewska JP, et al. The Composition of Surgical Wound Fluids from Breast Cancer Patients is Affected by Intraoperative Radiotherapy Treatment and Depends on the Molecular Subtype of Breast Cancer. Cancers. 2020;12(1):124–132. PMID: 31861498. PMCID: PMC7016654. https://doi.org/10.3390/cancers12010011Kulcenty K, Piotrowski I, Wróblewska JP, et al. The Composition of Surgical Wound Fluids from Breast Cancer Patients is Affected by Intraoperative Radiotherapy Treatment and Depends on the Molecular Subtype of Breast Cancer. Cancers. 2020;12(1):124–132. PMID: 31861498. PMCID: PMC7016654. https://doi.org/10.3390/cancers12010011Krengli M, Sedlmayer F, Calvo FA, et al. ISIORT pooled analysis 2013 update: clinical and technical characteristics of intraoperative radiotherapy. Transl Cancer Res. 2014;3(1):48–58. http://doi.org/10.3978/j.issn.2218-676X.2014.01.02Krengli M, Sedlmayer F, Calvo FA, et al. ISIORT pooled analysis 2013 update: clinical and technical characteristics of intraoperative radiotherapy. Transl Cancer Res. 2014;3(1):48–58. http://doi.org/10.3978/j.issn.2218-676X.2014.01.02Kusters M, Valentini V, Calvo FA, et al. Results of European pooled analyses of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol. 2010;21:1279–1284. https://doi.org/10.1093/annonc/mdp501Kusters M, Valentini V, Calvo FA, et al. Results of European pooled analyses of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol. 2010;21:1279–1284. https://doi.org/10.1093/annonc/mdp501Valentini V, Calvo F, Reni M, et al. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol. 2009;9:54–59. PMID: 18762346. https://doi.org/10.1016/j.radonc.2008.07.020Valentini V, Calvo F, Reni M, et al. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol. 2009;9:54–59. PMID: 18762346. https://doi.org/10.1016/j.radonc.2008.07.020Comas С, Prio A. Irradiation roentgen preventive intraabdominal, après l’intervention chirurgicale dans un cas de cancer de l’uterus. Congres International d’Electrologie, Imprenta Francesca Badia, Barcelona 1906. (In French).Comas С, Prio A. Irradiation roentgen preventive intraabdominal, après l’intervention chirurgicale dans un cas de cancer de l’uterus. Congres International d’Electrologie, Imprenta Francesca Badia, Barcelona 1906. (In French).Abe M, Fukuda M, Yamano K, et al. Intra-Operative Irradiation in Abdominal and Cerebral Tumours. Acta Radiol Ther Phys Biol. 1971;10(4):408–416. PMID: 4107080. https://doi.org/10.3109/02841867109130786Abe M, Fukuda M, Yamano K, et al. Intra-Operative Irradiation in Abdominal and Cerebral Tumours. Acta Radiol Ther Phys Biol. 1971;10(4):408–416. PMID: 4107080. https://doi.org/10.3109/02841867109130786Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial. Lancet. 2014;383(9917):603–613. PMID: 24224997. http://doi.org/10.1016/S0140-6736(13)61950-9Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial. Lancet. 2014;383(9917):603–613. PMID: 24224997. http://doi.org/10.1016/S0140-6736(13)61950-9Chirag Sh. Intraoperative Radiation Therapy for Breast Cancer: Are We There Yet? Ann Surg Oncol. 2021;28:20–22. PMID: 33206264. https://doi.org/10.1245/s10434-020-09356-yChirag Sh. Intraoperative Radiation Therapy for Breast Cancer: Are We There Yet? Ann Surg Oncol. 2021;28:20–22. PMID: 33206264. https://doi.org/10.1245/s10434-020-09356-yHarris E, Small WJr. Intraoperative Radiotherapy for Breast Cancer. Front Oncology. 2017;22:310–317. https://doi.org/10.3389/fonc.2017.00317Harris E, Small WJr. Intraoperative Radiotherapy for Breast Cancer. Front Oncology. 2017;22:310–317. https://doi.org/10.3389/fonc.2017.00317Elizabeth O, Martin CT, Bindu VM, et al. Outcomes with intraoperative radiation therapy for early-stage breast cancer. Breast J. 2020;26(3):454–457. PMID: 31562688. https://doi.org/10.1111/tbj.13574Elizabeth O, Martin CT, Bindu VM, et al. Outcomes with intraoperative radiation therapy for early-stage breast cancer. Breast J. 2020;26(3):454–457. PMID: 31562688. https://doi.org/10.1111/tbj.13574Sedlmayer F, Reitsamer R, Wenz F, et al. Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiation Oncology. 2017;12(1):23–35. PMID: 28103903. PMCID: PMC5244574. https://dx.doi.org/10.1186%2Fs13014-016-0749-9Sedlmayer F, Reitsamer R, Wenz F, et al. Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiation Oncology. 2017;12(1):23–35. PMID: 28103903. PMCID: PMC5244574. https://dx.doi.org/10.1186%2Fs13014-016-0749-9Пасечникова Е.А., Бодня В.Н., Кадомцев Д.В., и др. Роль интраоперационной лучевой терапии в комплексном лечении рака молочной железы: современное состояние проблемы. Современные проблемы науки и образования. 2020;1. https://doi.org/10.17513/spno.29491Pasechnikova EA, Bodnya VN, Kadomtsev DV, et al. The role of intraoperative radiation therapy in the complex treatment of breast cancer: current state of the problem. Modern problems of sci­ ence and education. 2020;1. (In Russ.). https://doi.org/10.17513/spno.29491König L, Lang K, Heil J, et al. Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients – First Clinical Results From a Single Center. Frontiers in Oncology. 2019;9:384–394. https://doi.org/10.3389/fonc.2019.00384König L, Lang K, Heil J, et al. Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients – First Clinical Results From a Single Center. Frontiers in Oncology. 2019;9:384–394. https://doi.org/10.3389/fonc.2019.00384Jacobs DH, Horeweg N, Straver M, et al. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimes. Breast Cancer Res Treat. 2021;189(2):387–398. PMID: 34216316. PMCID: PMC8357747. https://dx.doi.org/10.1007%2Fs10549-021-06314-4Jacobs DH, Horeweg N, Straver M, et al. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimes. Breast Cancer Res Treat. 2021;189(2):387–398. PMID: 34216316. PMCID: PMC8357747. https://dx.doi.org/10.1007%2Fs10549-021-06314-4Гринев И.А. Интраоперационная лучевая терапия у больных раком молочной железы после неоадъювантного лекарственного лечения: дис. … канд. мед. наук. СПб.; 2017.Grinev IA. Intraoperative radiation therapy in breast can­ cer patients after neoadjuvant drug treatment. Dissertation. Saint Petersburg; 2017. (In Russ.).Трофимова О.П., Ткачев С.И., Хайленко В.А., и др. Лучевая терапия в органосохраняющем лечении больных раком молочной железы – что изменилось? Онкология. 2013;2:53–56.Trofimova OP, Tkachev SI, Khailenko VA, et al. Radiation therapy in the organ-conserving treatment of patients with early breast cancer – what has changed? Oncology. 2013;2:53–56. (In Russ.).Keshtgar MR, Vaidya JS, Tobias JS, et al. Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible. Int J Radiat Oncol Biol Phys. 2011;80(1):31–38. PMID: 20646864. https://doi.org/10.1016/j.ijrobp.2010.01.045Keshtgar MR, Vaidya JS, Tobias JS, et al. Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible. Int J Radiat Oncol Biol Phys. 2011;80(1):31–38. PMID: 20646864. https://doi.org/10.1016/j.ijrobp.2010.01.045Kaiser J, Reitsamer R, Kopp P, et al. Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer. Breast Care (Basel). 2018;13(3):162–167. PMID: 30069175. PMCID: PMC6062668. https://doi.org/10.1159/000489637Kaiser J, Reitsamer R, Kopp P, et al. Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer. Breast Care (Basel). 2018;13(3):162–167. PMID: 30069175. PMCID: PMC6062668. https://doi.org/10.1159/000489637Тер-Ованесов М.Д., Кукош М.Ю. Интраоперационная лучевая терапия: вчера, сегодня, завтра (обзор литературы). Медицинский алфавит. 2017;3(35):23–28.Ter-Ovanesov MD, Kukosh MYu. Intraoperative radiation therapy: yesterday, today, future. Medical alphabet. 2017;3(35):23–28. (In Russ.).Канаев С.В., Новиков С.Н., Брянцева Ж.В. и др. Сравнительный анализ возможностей внутритканевой брахитерапии источниками высокой мощности дозы и облучения электронами при подведении дополнительной дозы облучения на ложе удаленной опухоли молочной железы. Вопросы онкологии. 2018;64(3):303–309. https://doi.org/10.37469/0507-3758-2018-64-3-303-309Kanaev SV, Novikov SN, Bryantsev ZhV, et al. Comparison between high dose rate brachytherapy and electron beam radiation in patients who received additional radiation to the tumor bed of removed breast tumor. Questions of oncology. 2018;64(3):303–309. (In Russ.). https://doi.org/10.37469/0507-3758-2018-64-3-303-309Акулова И.А., Новиков С.Н., Целуйко А.И. и др. Сравнительный анализ косметических результатов проведенного лечения у пациенток с дополнительным облучением ложа опухоли при раке молочной железы. Опухоли женской репродуктивной системы. 2020;16(3):57–66. http://doi.org/10.17650/1994-4098-2020-16-3-56-66Akulova IA, Novikov SN, Tseluyko AI, et al. Comparison of cosmetic results after treatment in women with breast cancer who received additional radiation to the tumor bed. Tumors of female reproductive system. 2020;16(3):57–66. (In Russ.). http://doi.org/10.17650/1994-4098-2020-16-3-56-66

The authors declare that there are no conflicts of interest present.